Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.44 |
| ▸ | MAOB | P27338 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | CASP1 | P29466 | 1/20 | 0.43 |
| ▸ | CNR2 | P34972 | 1/20 | 0.43 |
| ▸ | CASP7 | P55210 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7789366 | 0.95 | MAOB (0.48) | ALDH1A1KDM4EMAOBMAPTSMN1; SMN2 | |
| SCHEMBL11217204 | 0.88 | MAOB (0.55) | ALDH1A1KDM4EMAOBMAPTSMN1; SMN2 | |
| SCHEMBL51591 | 0.87 | ALDH1A1 (0.56) | ALDH1A1KDM4EMAOBMAPTSMN1; SMN2 | |
| SCHEMBL52567 | 0.86 | ALDH1A1 (0.49) | ALDH1A1KDM4EMAOBMAPTSMN1; SMN2 | |
| SCHEMBL11221933 | 0.84 | MEN1 (0.49) | ALDH1A1KDM4EMAOBMAPTSMN1; SMN2 | |
| SCHEMBL3843889 | 0.83 | ALDH1A1 (0.53) | ALDH1A1KDM4EMAOBSMN1; SMN2RAB9A | |
| SCHEMBL7786906 | 0.82 | MAOB (0.41) | ALDH1A1KDM4EMAOBMAPTSMN1; SMN2 | |
| SCHEMBL52048 | 0.82 | ALDH1A1 (0.58) | ALDH1A1KDM4EMAOBSMN1; SMN2RAB9A | |
| SCHEMBL51758 | 0.82 | CYP3A4 (0.54) | ALDH1A1KDM4EMAOBMAPTSMN1; SMN2 | |
| SCHEMBL6836185 | 0.80 | MAOB (0.49) | ALDH1A1KDM4EMAOBMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11382868-B2 | Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same | ICURE PHARMACEUTICAL INC. (KR) | 2022-07-12 | — | — | US | claimed |
| US-10919909-B2 | Photoinitiated reactions | LINTFIELD LIMITED (GB) | 2021-02-16 | — | — | US | claimed |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | LINTFIELD LIMITED (GB) | 2019-07-11 | — | — | US | claimed |
| US-20190046463-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | ICURE PHARMACEUTICAL INC. (KR) | 2019-02-14 | — | — | US | claimed |
| EP-3415141-A1 | ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME | Icure Pharmaceutical Inc. (KR) | 2018-12-19 | — | — | EP | claimed |
| US-4366228-A | 3-KETOCOUMARIN DERIVATIVES AS PHOTOSENSITIZERS; ALPHA-PHENYLOXYALKYLENECARBOXYLIC ACIDS AS ACTIVATORS; HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1982-12-28 | — | — | US | claimed |
| US-4289844-A | 3-KETO-COUMARIN DERIVATIVES, HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1981-09-15 | — | — | US | claimed |
| EP-0022188-A2 | Co-initiator compositions for photopolymerization containing 3-acyl-substituted coumarins, photopolymerizable composition and photographic element | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1981-01-14 | — | — | EP | claimed |
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| US-20250149336-A1 | PHOTORESIST COMPOSITION AND METHOD OF MANUFACTURING INTEGRATED CIRCUIT DEVICE USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-05-08 | — | — | US | disclosed |
| CN-114129544-B | Ultraviolet curable hydrogel resin for transdermal administration, hydrogel, and cataplasm comprising same | Icure药品株式会社 | 2025-03-21 | — | — | CN | disclosed |
| CN-119403840-A | Photocurable composition, method for producing cured film, solid-state imaging element, image display device, and radical polymerization initiator | 富士胶片株式会社 | 2025-02-07 | — | — | CN | disclosed |
| WO-2025011754-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2025-01-16 | — | — | WO | disclosed |
| EP-4114825-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| EP-0272215-A2 | Process for obtaining images | CIBA-GEIGY AG (CH) | 1988-06-22 | — | — | EP | disclosed |
| EP-0269568-A2 | Polymerisable compositions | CIBA-GEIGY AG (CH) | 1988-06-01 | — | — | EP | disclosed |
| EP-0207893-A2 | Image-forming process | CIBA-GEIGY AG (CH) | 1987-01-07 | — | — | EP | disclosed |
| US-4366228-A | 3-KETOCOUMARIN DERIVATIVES AS PHOTOSENSITIZERS; ALPHA-PHENYLOXYALKYLENECARBOXYLIC ACIDS AS ACTIVATORS; HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1982-12-28 | — | — | US | disclosed |
| US-4289844-A | 3-KETO-COUMARIN DERIVATIVES, HIGH SPEED | EASTMAN KODAK COMPANY (US) | 1981-09-15 | — | — | US | disclosed |
| EP-0022188-A2 | Co-initiator compositions for photopolymerization containing 3-acyl-substituted coumarins, photopolymerizable composition and photographic element | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1981-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10919909-B2 | Photoinitiated reactions | KMO, DECR1, PPOX | ALDH1A1 262/4885KDM4E 2292/4885MAOB 183/4885 |
| US-20190211031-A1 | PHOTOINITIATED REACTIONS | DOHH, PAH, DBH | ALDH1A1 179/4885KDM4E 1292/4885MAOB 506/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.